New 3D imaging reveals how pancreatic islet structure may influence beta cell loss in Type 1 diabetes

The pancreatic islets—clusters of hormone-producing cells scattered throughout the pancreas—have long been difficult to study in detail. Researchers have lacked a clear, comprehensive picture of how these islets are organized, how many cells they contain, and how their structure differs between healthy people and those with Type 1 diabetes.

A new study published in Nature Communications used advanced 3D imaging techniques to examine pancreatic tissue from multiple groups of donors: those without diabetes, those with autoantibodies suggesting high risk, and those with recently diagnosed Type 1 diabetes. The goal was to create a high-resolution map of islet structure in health and disease.

The research revealed that in people without diabetes, approximately 50% of islets are composed almost entirely of insulin-producing beta cells and lack glucagon-producing alpha cells. This prevalence of insulin-only islets had not been fully appreciated before.

Interestingly, people who carry a single diabetes autoantibody (specifically, the GADA autoantibody) but have not yet developed Type 1 diabetes showed islet structures remarkably similar to healthy age-matched controls. This suggests that autoantibody presence alone does not immediately alter the physical structure or composition of islets.

In contrast, pancreases from people with short-duration Type 1 diabetes showed striking differences. The islet density—the number of islets per unit of pancreatic tissue—was significantly reduced. More remarkably, the smaller insulin-only islets were lost at high rates.

The larger islets that contain both insulin and glucagon cells, however, were preserved. This selective loss of certain islet types suggests that islet size and cellular composition may be important factors in determining which beta cells survive the immune attack that characterizes Type 1 diabetes.

These findings provide new insight into the structural basis of beta cell loss in Type 1 diabetes. The pattern of selective destruction—where smaller, insulin-only islets disappear while larger, mixed-cell islets persist—suggests that physical characteristics of islets influence their vulnerability to immune attack.

Understanding these structural differences may help researchers identify new targets for interventions aimed at protecting beta cells. The research highlights the importance of examining not just the number of islets and cells, but also their organization and composition, when studying Type 1 diabetes development.

Origin: nature.com (News report). Evidence: News report, corroborated with 3 indexed studies. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.